Issuu on Google+

ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email!

Autoimmune Disease Therapeutics to 2016 Published on May 2012

Report Summary As a group, autoimmune diseases represent one of the most intractable families of conditions facing medical science. The complexities and genetic underpinnings of the human immune response result in a set of disease targets that are at once physiologically ubiquitous and highly individualized. Until recently, autoimmune disease patients were given little hope for an effective treatment. But the convergence an of improved understanding of autoimmune disease mechanisms and the availability of recombinant cytokines has led to systemic treatments that, while not devoid of side effects, have demonstrated the ability to control autoimmune reactions in a significant number of patients. A number of potentially important pipeline drugs hold the promise of future improvements in outcomes for autoimmune disease patients. This study analyzes current autoimmune therapeutics and assesses the next-generation of candidates and their probable impact on treatment options and the competitive landscape. Highlights ' Analyzes current therapeutic options for autoimmune diseases, and evaluates emerging therapeutic candidates and assesses their commercial potential ' Assesses existing and evolving immune disease mechanisms and treatment strategies ' Analyzes more than two dozen existing and emerging autoimmune disease targets and target-specific therapeutic drug products ' Evaluates regional and global opportunities for autoimmune therapeutics ' Provides market data and forecasts for six major autoimmune disease segments to 2016

Table of Content Executive Summary Autoimmune Therapeutics Segment Dynamics Sector Market Dynamics Patient Demographics and Growth Chronic Disease and Self-administration Managed Care and Prescribing Trends Factors Limiting Growth Industry Alignment and Competitive Landscape Autoimmune Therapeutic Market Assessments Arthritis Disease Forms and Immune Mechanisms Therapeutic Strategies Disease Demographics and Growth Key Approved Therapies

Autoimmune Disease Therapeutics to 2016 (From Issuu)

Page 1/4


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Development-stage Candidate Assessment Market Factors Commercial Outlook and Forecasts Crohn's Disease Disease Incidence and Demographics Current Generation Treatment Options Therapies in Development Market Factors Commercial Outlook and Forecasts Diabetes Restoring Islet Cell Function Therapies in Development Commercial Outlook and Forecasts Lupus The Ongoing Unmet Need Pipeline Candidates ' A Ray of Hope Market Factors The Potential for a Lupus-specific Therapy Commercial Outlook and Forecasts Multiple Sclerosis Disease Mechanisms and Therapeutic Strategies The Market Opportunity Competitive Landscape Development-stage Candidate Assessment Market Factors Commercial Outlook and Forecasts Psoriasis Therapeutic Options and Expanded Indications Prescribing Trends and Drug Efficacy Market Sector Factors Development-stage Candidate Assessment Commercial Outlook and Forecasts Market Factors Risk Factors Clinical Trial Factors Product Issues Autoimmune Therapeutics ' Company Profile

Autoimmune Disease Therapeutics to 2016 (From Issuu)

Page 2/4


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ

Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93

If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information Please verify that the product information is correct and select the format(s) you require. Autoimmune Disease Therapeutics to 2016

Product Formats Please select the product formats and the quantity you require. 1 User License--USD 3 850.00

Quantity: _____

Site License--USD 5 500.00

Quantity: _____

Corporate License--USD 7 500.00

Quantity: _____

Contact Information Please enter all the information below in BLOCK CAPITALS

Title:

Mr

Mrs

Dr

Miss

Ms

Prof

First Name:

_____________________________ Last Name: __________________________________

Email Address:

__________________________________________________________________________

Job Title:

__________________________________________________________________________

Organization:

__________________________________________________________________________

Address:

__________________________________________________________________________

City:

__________________________________________________________________________

Postal / Zip Code:

__________________________________________________________________________

Country:

__________________________________________________________________________

Phone Number:

__________________________________________________________________________

Fax Number:

__________________________________________________________________________

Autoimmune Disease Therapeutics to 2016 (From Issuu)

Page 3/4


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card

Card Number: ______________________________________________

Expiry Date

__________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer

Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check

UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

 

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms

Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56

ƒ ƒ

Autoimmune Disease Therapeutics to 2016 (From Issuu)

Asia, Oceania and America : + 1 (805) 617 17 93

Page 4/4


Autoimmune Disease Therapeutics to 2016